Alasdair Coles, MD

CARE MS extension study results, discussed by Dr. Alasdair Coles at the 2014 Joint ACTRIMS-ECTRIMS meeting in Boston, provide further evidence of the prolonged efficacy of alemtuzumab on both relapses and disability in multiple sclerosis.